Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep415 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Flash glucose monitoring in patients with type 1 diabetes

Garcia-Ramirez Mireia , Moyano-Sanchez Ana Maria , Moreno-Moreno Paloma , Rebollo-Roman Angel , Galvez Moreno Maria Angeles

Objective: Flash glucose monitoring (FGM) allows non-invasive glucose level assessment. Our objective was to describe the characteristics of these patients and their glycemic control expressed as HbA1c and times in range. Methods and patientsObservational longitudinal clinical study between January 2021 and December 2021 in patients with DM1 between 14 and 18 years. Results 95 patients included. Mean age: 16.64 ± 1.25 years, with a mean DM evolution time of 6.46 ± 3....

ea0041gp46 | Bone & Calcium Homeostasis (1) | ECE2016

Denosumab increases bone mineral density in primary hyperparathyroidism treated with cinacalcet

Munoz Jimenez Concepcion , Manuel Quesada Gomez Jose , Moreno Moreno, Maria Rosa Alhambra Exposito Paloma , Inmaculada Prior Sanchez Maria , Angeles Galvez Moreno Maria

Cinacalcet decreases and normalizes serum calcium levels across a broad severity range of primary hyperparathyroidism (PHPT), slightly reduces parathyroid hormone levels which generally remains elevated, whereas it has no effect on bone mineral density (BMD). Therefore, when administering cinacalcet to a patient with PHPT, concomitant treatment with an anti-catabolic drug should be considered.An open-labeled, prospective trial was conducted in 32 patient...

ea0081ep964 | Thyroid | ECE2022

Therapeutic approach to the diagnosis of Bethesda 5

Barrera-Martin Ana , Rosa Alhambra Exposito Mª , Moreno-Moreno Paloma , Angeles Galvez Moreno Maria

Introduction: Thyroid nodules are very common in the general population (20-75% ultrasound). There are clinical management criteria established by international societies and standardized cytological diagnostic criteria (Bethesda). However, there is still uncertainty in the management of category 5.Objectives: To evaluate the clinical attitude to the cytological diagnosis of Bethesda category 5 (B5) in thyroid fine-needle aspiration cytology (FNA). And s...

ea0063gp93 | Thyroid Nodules and Cancer | ECE2019

Tirads classification and final diagnosis of thyroid nodules classified as bethesda-3 after fine-needle aspiration

Rosa Alhambra Exposito Maria , Barrera Martin Ana , Segui Azpilcueta Pedro , Angeles Galvez Moreno Maria

Introduction: Ultrasound is the main diagnostic tool for imaging pathology of the thyroid gland. The TI-RADS classification allows the evaluation of a risk of malignancy in the case of thyroid nodules, indicating the need to perform a puncture for a histological study. Bethesda system classifies them according to the cytological malignancy risk. Bethesda category 3 (B3) comprises ‘follicular lesion of undetermined significance’ or ‘atypia of undetermined signifi...

ea0063p282 | Pituitary and Neuroendocrinology 1 | ECE2019

Cushing disease: Clinical presentation

Moreno-Moreno Paloma , Munoz-Jimenez Concepcion , Barrera-Martin Ana , Galvez-Moreno Maria Angeles

Objective: Cushing’s disease (CD) accounts for approximately 80% of cases of Cushing’s syndrome. Its clinic is nonspecific and its diagnosis difficult. The objective of this study is to review the most frequent clinical signs of this disease in our environment and compare it with that described in the literature.Patients and methods: Retrospective descriptive study of patients with CD. We included all patients diagnosed with CD (2005–2017)...

ea0063p287 | Pituitary and Neuroendocrinology 1 | ECE2019

Diagnostic tests in Cushing’s disease

Moreno-Moreno Paloma , Alcantara-Laguna Maria Dolores , Leon-Idougourram Soraya , Galvez-Moreno Maria Angeles

Objective: Cushing’s disease (CD) accounts for approximately 80% of cases of Cushing’s syndrome. Diagnosis of CD is difficult, it is carried out with a screening test and confirmation test. The aim of this study is to describe the diagnostic results of the different diagnostic tests used in the diagnosis of CD in our environment.Patients and methods: Retrospective descriptive study of patients with CD. We included all patients diagnosed with CD...

ea0049ep474 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Debut diabetes characteristics

Exposito Maria Rosa Alhambra , Sanchez Inmaculada Prior , Moreno Paloma Moreno , Moreno Maria Angeles Galvez

Background: The diabetes type 1 (DM1) is a chronic autoimmune disease, it tends to appear in childhood, its incidence continues to rise and the complications arising from improper care poses serious health problems for those who suffer. LADA diabetes is autoimmune diabetes which appear in adults.Objetive: To describe the characteristics of the new diabetes debut in our environment.Material and methods: We included all patients who ...

ea0049ep1159 | Male Reproduction | ECE2017

Induction of male puberty in patients with hypogonadism hypogonadotrope with subcutaneous gonadotropin

Moreno-Moreno Paloma , Munoz-Jimenez Concepcion , Alhambra-Exposito Maria Rosa , Galvez-Moreno Maria Angeles

Objective: The most used therapeutic guidelines for the induction of male puberty in hypogonadotropic hypogonadism (HH) are GnRH in subcutaneous pulsatile infusion and HCG in monotherapy or combined with FSH in intramuscular injection. The objective of this study was to evaluate the efficacy of subcutaneous HCG with or without FSH in induction of male puberty in patients with HH.Patients and methods: Descriptive study of patients with HH treated with HCG...

ea0041ep753 | Neuroendocrinology | ECE2016

Prognostic factors of pituitary growth hormone-secreting tumors

Alhambra Exposito Maria Rosa , Ibanez Costa Alejandro , Moreno Paloma Moreno , Galvez Moreno Maria Angeles

Background: Acromegaly is the consequence of excessive growth hormone (GH) secretion, usually produced by a pituitary adenoma. Transphenoidal surgery is the first-choice treatment; however, the development of new drug therapies in the last years, specially the somatostatin analogues (SSA), has open new and promising avenues for the treatment of pituitary tumors.Objective: To determine whether a detailed knowledge of the clinico-pathological and radiologi...

ea0037ep441 | Diabetes (complications & therapy) | ECE2015

Glargine insulin treatment during pregnancy in type 1 diabetes mellitus

Moreno-Moreno Paloma , Palomares-Ortega Rafael , Munoz-Jimemez Concepcion , Galvez-Moreno Maria Angeles

Objective: The aim of this study was to evaluate maternal and neonatal outcomes in women with type 1 diabetes mellitus (DM1), and analysing differences associated to insulin glargine exposure during pregnancy.Patients and methods: Retrospective descriptive study of pregnancies in women with DM1 (2004–2012). Variables analysed: baseline characteristics (age, time of diabetes evolution, microvascular complications, and weight), maternal outcomes (weig...